Foley Represents Ambassador Theatre Group in Acquisition of Three High-End Theatres

24 March 2021 Media Contact: Jen Dilworth News

Foley & Lardner LLP served as lead counsel on behalf of Ambassador Theatre Group in its acquisition of three high-end venues, including San Francisco’s Golden Gate Theatre and Orpheum Theatre and Detroit’s Fisher Theatre – important markets for touring Broadway productions – as well as the theatrical programming operations of the Detroit Opera House and Music Hall in Detroit. Private equity investment firm Providence Equity Partners backed Ambassador Theatre Group in the transaction.

In business for nearly 30 years, the Ambassador Theatre Group owns more than 50 prominent West End theaters, Broadway’s Lyric and Hudson theaters, as well as venues in Germany, Texas, New Orleans, Boston and Brooklyn.

The Foley team was led by partner Michael Rogers and also included partners Gregory Meeks, Gregory Neppl, Pamela Brown, Dorothy Watson, Jeffrey Kopp, James Howard, Gregg Dooge and Chanley Howell, and associates Danielle Osburn and George Khalaf. Foley provided corporate, Hart-Scott-Rodino (HSR), real estate, environmental, labor, tax, employee benefits and intellectual property counsel to the Ambassador Theatre Group.

Media coverage of the transaction was vast, spanning outlets such as Variety, Deadline, Yahoo! News, Broadway World and Crain’s Detroit Business, among others.

Insights

Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
$4.24M Now the Average Cost Per Data Breach!
30 July 2021
Internet, IT & e-Discovery Blog
Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
Foley Podcast to Live Panel Discussion
29 July 2021
Foley Career Perspectives
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream